China Pharma (NYSE:CPHI) Coverage Initiated at StockNews.com

Stock analysts at StockNews.com began coverage on shares of China Pharma (NYSE:CPHI) in a research report issued on Saturday. The firm set a “hold” rating on the stock.

China Pharma Trading Down 3.4 %

Shares of NYSE:CPHI opened at $0.24 on Friday. The business’s 50 day moving average is $0.22 and its 200 day moving average is $0.22. China Pharma has a 52-week low of $0.13 and a 52-week high of $0.44. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.79 and a quick ratio of 0.26.

About China Pharma

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.